• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 5. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506

Introduction to 3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5)

3-Amino-N-methyl-N-phenylbenzamide, identified by the Chemical Abstracts Service Number (CAS No.) 14309-78-5, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This molecule, characterized by its benzamide core structure functionalized with an amino group at the 3-position and N-methylation, has garnered attention due to its versatile applications in medicinal chemistry and drug discovery. The benzamide moiety is a well-documented pharmacophore, frequently encountered in therapeutic agents targeting various biological pathways. The presence of an amino group at the 3-position and N-methyl substitution introduces unique electronic and steric properties, making this compound a valuable scaffold for designing novel bioactive molecules.

The structural motif of 3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5) allows for extensive chemical modifications, enabling the exploration of diverse pharmacological profiles. In recent years, there has been a surge in research focusing on amide-based compounds due to their potential to modulate enzyme activity and receptor interactions. Specifically, benzamides have been extensively studied for their roles in anti-inflammatory, analgesic, and neuroprotective applications. The incorporation of an amino group at the 3-position enhances the compound's solubility and bioavailability, which are critical factors in drug formulation and delivery.

Recent advancements in computational chemistry and molecular modeling have further illuminated the mechanistic aspects of 3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5). Studies employing high-throughput virtual screening (HTVS) have identified this compound as a promising candidate for inhibiting key enzymes involved in metabolic disorders. The N-methyl group contributes to steric hindrance, which can be exploited to optimize binding affinity to target proteins. Additionally, the phenyl ring provides a hydrophobic surface that can interact favorably with lipid rafts in cell membranes, potentially enhancing drug uptake and intracellular trafficking.

In the context of drug development, 3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5) has been investigated for its potential role in modulating neurotransmitter systems. Preclinical studies suggest that derivatives of this compound may exhibit properties similar to classical benzodiazepines but with improved safety profiles. The amino group at the 3-position allows for further derivatization into more complex structures, such as peptidomimetics or heterocyclic analogs, which could lead to the discovery of next-generation therapeutics for central nervous system disorders.

The synthesis of 3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5) involves well-established organic reactions, including nucleophilic substitution and condensation reactions. Advanced synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions, have been employed to enhance yield and purity. These techniques are particularly valuable in constructing complex molecular frameworks while maintaining high regioselectivity and stereoselectivity. The growing interest in green chemistry has also prompted researchers to explore solvent-free or aqueous-phase synthesis routes for this compound, aligning with global efforts to minimize environmental impact.

The pharmacokinetic properties of 3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5) have been scrutinized through in vitro and in vivo studies. Metabolic stability assessments indicate that this compound undergoes moderate biotransformation via cytochrome P450 enzymes, suggesting potential interactions with co-administered drugs that share metabolic pathways. However, preliminary data suggest that N-demethylation is not a major route of elimination, which could be advantageous for reducing toxicity associated with reactive metabolites.

Future research directions for 3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5) include exploring its role as a prodrug or precursor for more potent derivatives. The flexibility of its molecular structure allows for the introduction of additional functional groups that could enhance target specificity or improve pharmacokinetic profiles. For instance, incorporating fluorine atoms or other halogenated substituents could modulate metabolic stability while maintaining biological activity.

The broader significance of this compound lies in its potential as a building block for libraries of bioactive molecules. High-throughput screening campaigns utilizing 3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5) or its derivatives could uncover novel therapeutic agents with applications ranging from oncology to infectious diseases. Collaborative efforts between academic institutions and pharmaceutical companies are essential to accelerate these discoveries and translate laboratory findings into clinical benefits.

In conclusion,3-Amino-N-methyl-N-phenylbenzamide (CAS No. 14309-78-5) represents a compelling subject of study in pharmaceutical chemistry due to its structural versatility and potential biological relevance. Ongoing research efforts are expected to yield new insights into its pharmacological properties and applications, reinforcing its importance as a key intermediate in drug discovery initiatives worldwide.

• 785-30-8(4-amino-N-(4-aminophenyl)benzamide)
• 93-98-1(N-Phenylbenzamide)
• 17625-83-1(4’-Aminobenzanilide)
• 23099-05-0(3-Methylbenzanilide)
• 14315-16-3(3-Amino-N-phenylbenzamide)
• 1934-92-5(N-Methylbenzanilide)
• 74441-06-8(p-Aminobenzoylbenzamide)
• 782-45-6(4-Amino-N-phenylbenzamide)
• 101-12-2(Benzamide,3-amino-N-(3-aminophenyl)-)
• 2657-93-4(3,4'-Diamino Benzanilide)